Dulaglutide (Trulicity) Dulaglitide is a once-weekly GLP-1 agonist that is FDA-approved for promoting glycemic control in patients with type 2 diabetes
If theres another option in the arsenal of weight loss drugs, thats greatbut a full-on comparison to tirzepatide will need to be determined
The dual agonism is why tirzepatide produces greater weight loss than semaglutide, a selective GLP-1 agonist, as seen in trials comparing the two agents
However, women supplementing l carnitine later that age were seen to have improved bone health
Wegovy also made history as the first weight-loss medication to demonstrate a measurable cardiovascular benefit
Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M, Tabit CE, et al